BLOOD TRANSFUSION DEVICES MARKET ANALYSIS

Blood Transfusion Devices Market, By Product Type (Pathogen Reduction System, Apheresis Devices, Blood Component Separator, Blood Bag & Accessory, Venous Access Devices, Others (Filters, Blood Mixer, Fridge & Freezer)), By End User (Hospital, Ambulatory Surgical Centers, Blood Bank, Others (Research & Academic Institutes, etc.)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Global Blood Transfusion Devices Market: Key Developments

On September 6, 2023, Vitestro, a medical robotics company, initiated A.D.O.P.T. Trial for its autonomous blood drawing device. This is the most significant study of autonomous blood collection, with a sample size of over 10,000 patients. Vitestro anticipates obtaining CE certification by the end of 2024. The Vitesro system combines AI-based, ultrasound-guided 3D reconstruction with robotic needle insertion to provide accurate and consistent venipuncture.
In January 2020, Fresenius Kabi, a global health care company, announced US$ 31.6 Mn (EUR 30 million) expansion of its Dominican Republic transfusion and apheresis disposables plant. The company expanded to meet the increasing demand for these high-quality disposables. The new facility houses advanced manufacturing technology, plasma kit assembly lines, and sterilization units, and thus, effectively doubling the cleanroom and storage capacity. The site also includes a large warehouse.

Blood Transfusion Devices Market Report Snapshots